Comparison of Adjunctive Naoxintong versus Clopidogrel in Volunteers with the CYP2C19*2 Gene Mutation Accompanied with Qi Deficiency and Blood Stasis Constitution
Table 1
Subject characteristics.
Age (year)
BMI (Kg/m2)
BP (mmHg)
Hb (g/L)
Platelet count (×109/L)
FSG (mmol/L)
CGCCr (ml/min)
AST (μ/L)
ALT (μ/L)
TC (mmol/L)
CYP2C19*2 genotypes
1
33
21.8
130/70
134.0
257.0
4.93
92.1
36.6
38.6
5.3
CYP2C19*1/*1
2
36
21.0
118/70
136.0
204.0
5.19
89.3
33.3
37.3
5.0
CYP2C19*1/*1
3
38
19.8
118/80
153.0
295.0
4.69
87.6
38.7
38.9
5.4
CYP2C19*1/*1
4
48
22.1
120/70
152.0
189.0
4.69
88.2
34.6
36.4
5.2
CYP2C19*1/*1
5
35
21.7
110/70
167.0
240.0
4.68
90.2
33.2
33.3
4.1
CYP2C19*1/*1
6
36
24.5
102/80
125.0
231.0
4.96
84.6
37.8
38.7
4.6
CYP2C19*1/*1
7
42
22.8
120/80
126.0
269.0
6.33
87.5
32.9
39.2
5.4
CYP2C19*1/*2
8
35
23.9
116/70
135.0
273.0
4.88
91.6
39.6
37.7
3.6
CYP2C19*1/*2
9
32
21.3
120/80
154.0
271.0
5.44
92.3
33.7
38.1
5.6
CYP2C19*1/*2
10
34
23.5
106/74
133.0
218.0
6.96
111.6
36.5
38.8
5.0
CYP2C19*1/*2
11
34
20.1
108/70
164.0
217.0
4.68
119.8
37.9
36.7
3.4
CYP2C19*1/*2
12
37
23.4
120/80
156.0
298.0
4.48
116.6
38.8
37.7
4.1
CYP2C19*1/*2
13
36
18.4
120/80
153.0
288.0
4.98
87.9
38.1
37.3
3.9
CYP2C19*2/*2
14
43
21.1
120/70
152.0
293.0
6.6
86.3
40.0
39.4
3.9
CYP2C19*2/*2
15
45
24.2
124/84
145.0
298
5.39
87.7
38.2
39.0
5.2
CYP2C19*2/*2
16
35
21.6
100/70
139.0
217
5.55
102.3
36.9
34.6
4.3
CYP2C19*2/*2
17
41
20.6
108/84
149.0
203
4.19
106.6
37.5
35.7
4.2
CYP2C19*2/*2
18
39
23.1
116/80
145.0
284
5.32
95.4
36.7
37.5
5.1
CYP2C19*2/*2
Note: CGCCr is creatinine clearance rate calculated by Cockcroft/Gault formula.
